Guide to care questions
A plain-language guide to care offers
Use this guide to understand a BPC-157 offer and prepare questions for a care visit.
Open your check sheet
The peptide before the provider
BPC-157 is a peptide: its parts form a short chain and are also the building blocks of proteins.
BPC-157 is made in a lab. Its design uses a small piece of a protein that researchers say they found in fluid from the human stomach.
Begin with the health concern you need help to address. If you need someone to ask, begin with your usual doctor’s office. If you do not have a doctor, ask your health insurer or a local health centre how to find one.
Hope meets the evidence
The benefit question
Some rat studies reported better repair of injured tissue with BPC-157.
A dummy treatment has no active medicine.
As of September 2026, no study in people has reported whether BPC-157 heals injuries better than a dummy treatment.
A study comparing the treatments for a pulled thigh muscle has started, but it has no results yet, as of September 2026.
Comparing the groups helps researchers tell whether the medicine caused any improvement.
The unknowns question
The FDA says studies in people are too small and short to establish BPC-157’s safety, as of September 2026.
Not seeing a problem in a small study is not the same as ruling it out.
Ask what is still unknown for the use being offered to you.
The access question
When a medicine is made to order, usually by a pharmacy, that work is called compounding.
As of September 2026, US rules bar pharmacies from using raw ingredients to make BPC-157 for an individual patient.
The groups that asked the FDA to allow BPC-157 as a pharmacy ingredient took back their requests. Withdrawing those requests did not authorise pharmacies to use it, as of September 2026.
Larger facilities make batches of medicines for clinics under different rules. Giving the FDA their business details for its records does not mean they may legally supply BPC-157, as of September 2026.
This guide cannot confirm a lawful way for a larger facility to supply BPC-157.
A couple of loose ends
A research label does not mean the FDA approved it for people; no BPC-157 product is approved as of September 2026.
No BPC-157 medicine has FDA approval, as of September 2026. That leaves no published price for an approved product from a drug maker or the government.
This guide gives no likely price. To learn what an offer would cost you, get a written list showing separate charges for the visit, any tests, the proposed treatment and later care visits.
Put the questions to work
A care discussion can happen in person or through telehealth—talking with a medical professional online or by phone.
You do not need to have every answer before you start asking.